Press Release

The global anatomic pathology market revenue surpassed US$ 40.96 billion in 2024 and is predicted to attain around US$ 76.71 billion by 2033, growing at a CAGR of 7.22% during the forecast period from 2025 to 2033.

The demand for anatomic pathology is significantly influenced by the rising global burden of chronic diseases, particularly cancer, which impacts over 20 million individuals each year worldwide. Additionally, the expanding aging population—projected to surpass 1.5 billion people aged 65 and older by 2050—further fuels this demand. As the prevalence of chronic conditions increases with age, the need for accurate and timely diagnostic services becomes increasingly critical.

Several key products within the anatomic pathology market are experiencing heightened demand to meet these challenges. Among these are automated tissue processors, which enhance efficiency in sample preparation, and microtomes, essential for sectioning tissue samples for analysis. 

Furthermore, digital scanners are gaining popularity for their ability to facilitate high-resolution imaging and improve workflow in pathology labs. Alongside these technological advancements, consumables such as immunohistochemistry reagents and biopsy cassettes continue to play a vital role in diagnostic processes, ensuring that laboratories can provide accurate and reliable results for patient care.

Anatomic Pathology Market Key Takeaways

• The anatomic pathology market is projected to reach a valuation of US$ 76.71 billion by 2033, with a compound annual growth rate (CAGR) of 7.22% during the forecast period from 2025 to 2033
• By Product & Services, the services segment maintains a dominant position, commanding over 48.23% of the overall market share. This leadership highlights the critical role that diagnostic services play in the effective functioning of anatomic pathology, as healthcare providers increasingly rely on professional expertise for accurate diagnoses.
• In terms of application, the disease diagnostics segment is particularly noteworthy, contributing a substantial 74.42% of the revenue share within the anatomic pathology market. This significant figure reflects the ongoing demand for reliable diagnostic solutions that enable timely and precise identification of diseases, particularly in oncology.
• When considering end users, hospital laboratories lead the anatomic pathology market, capturing more than 48.01% of the market share. This predominance indicates that hospital settings are central to the delivery of anatomic pathology services, as they integrate advanced diagnostic technologies and skilled personnel to provide essential patient care.

Regional Analysis

Europe’s anatomic pathology market holds a leading position in the global landscape, primarily driven by the region's aging populations and stringent regulatory standards that prioritize quality and reproducibility in diagnostics. Countries like Germany and Italy have over 20% of their populations aged 65 and older, which significantly increases the demand for cancer diagnostics and the management of chronic diseases. 

This demographic trend has particularly heightened the need for accurate diagnostic solutions for prevalent malignancies, such as breast and colorectal cancers, where early detection and effective monitoring are crucial for improving patient outcomes. The emphasis on standardized pathology practices throughout Europe, guided by EU-wide regulatory frameworks, ensures that advanced diagnostic techniques are consistently adopted across member states. 

Innovations such as liquid biopsy and next-generation sequencing have gained traction due to their ability to provide detailed insights into tumor biology, enabling more precise treatment strategies. This standardization not only enhances the quality of diagnostics but also builds trust among healthcare providers and patients, as they can expect reliable and reproducible results regardless of the testing facility.

Moreover, the centralized healthcare systems in countries like the United Kingdom and France play a crucial role in facilitating reimbursement for molecular tests. This financial support incentivizes laboratories to invest in modern technologies, such as automated stainers and digital scanners, which improve efficiency and diagnostic accuracy. The integration of these advanced tools into pathology workflows streamlines operations and positions labs to better respond to the increasing volume of diagnostic requests stemming from an aging population.

Market Overview

The global market for anatomic pathology is experiencing significant growth, with forecasts indicating substantial expansion in the coming years. This growth is largely due to the increasing relevance of anatomic pathology within the healthcare sector, fueled by advancements in technology. As the healthcare landscape evolves, anatomic pathology is becoming an essential component of diagnostic practices, enhancing the ability to diagnose and treat various conditions.

The rising adoption of advanced pathology equipment, such as digital microscopes, gross imaging systems, and staining systems, is expected to enhance anatomic pathological practices. These innovations are transforming how pathologists analyze samples, leading to better outcomes for patients. Among these advancements, digital imaging solutions stand out for their ability to provide enhanced specificity and accuracy compared to traditional methods. This technological leap not only streamlines the diagnostic process but also minimizes the potential for human error, thereby increasing the reliability of results.

As healthcare providers seek to improve patient care and diagnostic processes, the demand for services that leverage these advanced technologies is rising. The growing emphasis on diagnostic precision and reliability is driving the market for anatomic pathology, as clinicians recognize the value of accurate and timely diagnoses in treatment planning. Consequently, this surge in demand for high-quality diagnostic solutions is propelling the adoption of digital imaging and other advanced pathology technologies, positioning anatomic pathology as a critical area of growth in the healthcare industry.

Market Growth Factors

Driver

Rising Cancer Cases Globally: The global increase in cancer cases has resulted in a substantial rise in the demand for anatomic pathology diagnostics. With cancer becoming one of the leading causes of morbidity and mortality worldwide, accurate and timely diagnostic services are critical for effective disease management and treatment planning.

Focus Towards Personalized Medicine: The shift towards personalized medicine—a tailored approach to treatment based on an individual’s unique genetic and molecular profile—has further amplified the demand for detailed pathological analysis services. This approach necessitates a deeper understanding of the specific characteristics of each patient's cancer.

Restraint

High Diagnostic Equipment Costs: The adoption of advanced anatomic pathology diagnostic technologies in developing regions is often constrained by high equipment costs. While innovations in medical technology, such as digital pathology systems and high-resolution imaging devices, have the potential to improve healthcare outcomes, the financial barriers associated with acquiring and maintaining this equipment can be prohibitive.

Global Shortage of Skilled Pathologists Affects: The shortage of skilled pathologists presents a significant challenge to timely service delivery in healthcare systems, particularly in developing regions. In areas with a scarcity of pathologists, patients may experience long wait times for diagnostic services. This delay can have dire consequences, particularly in cases where early intervention is crucial for effective treatment.

Top Trends

Revolutionizing Diagnostic Accuracy and Speed: Artificial intelligence (AI) and machine learning (ML) are transforming the field of anatomic pathology by significantly enhancing both diagnostic accuracy and speed. These advanced technologies analyze vast amounts of data from pathology slides, enabling pathologists to detect abnormalities more effectively and efficiently.

High-Resolution Digital Imaging and Global Collaboration: High-resolution digital imaging is another critical component revolutionizing anatomic pathology. This technology allows for the creation of detailed digital slides that can be easily shared and analyzed by healthcare professionals across the globe.

Recent Developments

• In April 2025, Paige, a leader in next-generation AI technology, announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to Paige PanCancer Detect. This AI-assisted diagnostic application is designed to aid pathologists in identifying suspicious cancer foci across multiple tissues and organs.
• In March 2025, JelloX Biotech Inc., a Taiwan-based startup pioneering in anatomic pathology, revealed the results of a recent clinical trial conducted in collaboration with Taipei Medical University Hospital (TMUH). The study, which focused on diagnosing and treating colorectal cancer, utilized JelloX's innovative 3D pathology methods on colonoscopy specimens. The findings highlighted a significant difference in pathological diagnoses, primarily due to the reclassification of cases into higher-risk categories compared to conventional 2D methods.
• In March 2025, Techcyte, a leader in AI-powered digital pathology, introduced Fusion, the first open, standards-based SaaS platform aimed at unifying anatomic and clinical pathology workflows.
• In February 2025, the American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, proudly announced the launch of LabVizor (LV). This advanced, cloud-based anatomic pathology laboratory information system (LIS) was developed with pathology practice management consultancy, SigmaCore.

Global Anatomic Pathology Market Key Players: 

• F. Hoffman La Roche Ltd
• Danaher Corp
• PHC Holdings Corp
• Abcam Ltd
• Hologic Inc
• Agilent Technologies Inc
• Becton Dickinson and Co
• Sakura Finetek USA Inc
• BioGenex
• Milestone Medical
• Histo-Line Laboratories
• Diapath S.p.A.
• Slee Medical Gmbh
• Merck KGAA
• Bio SB Inc.
• Other Prominent Players

Market Segmentation Overview:

By Product & Services

• Services
• Consumables
• Instruments

By Application

• Disease Diagnostics
• Medical Research

By End User

• Hospital Laboratories
• Clinical Laboratories
• Others

By Geography

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa (MEA)